Results 31 to 40 of about 98,103 (155)

Use of Dispersible Fixed-Dose Combinations in Chemotherapy of Drug Susceptible Tuberculosis: Results of the Observational Study

Туберкулез и болезни лёгких
The objective: to assess effectiveness, safety and pharmacoeconomic feasibility of using a dispersible fixed-dose combination (isoniazid 150 mg, rifampicin 150 mg, pyrazinamide 375 mg) in patients with respiratory tuberculosis and preserved ...
E. S. Nikitina, O. S. Ilyina, O. D. Baronova   +2 more
doaj   +1 more source

Early Administration of Rifampicin Does Not Induce Increased Resistance in Septic Two-Stage Revision Knee and Hip Arthroplasty

Antibiotics
Background/Objectives: Periprosthetic joint infection (PJI) is a severe complication that follows arthroplasty and occurs in approximately 2% of all cases. One of several cornerstones of therapy is an optimized antibiotic regimen. Early administration of
Leonard Grünwald, Benedikt Paul Blersch, Bernd Fink   +2 more
doaj   +1 more source

Formulation and evaluation of rifampicin sustained release tablets using juice of Citrus limetta as bio-retardant

Journal of Pharmacy and Bioallied Sciences, 2012
The advantages of biopolymers over synthetic polymers are low cost, natural origin, free from side effects, biocompatible, bio-acceptable, environmental friendly processing, local availability, better patient tolerance as well as public acceptance ...
K Pawan Gaur, Kulwant Soam, S K Gupta, Prashant Dabral   +3 more
doaj   +1 more source

Genetic Screen Reveals the Role of Purine Metabolism in Staphylococcus aureus Persistence to Rifampicin

Antibiotics, 2015
Chronic infections with Staphylococcus aureus such as septicemia, osteomyelitis, endocarditis, and biofilm infections are difficult to treat because of persisters.
Rebecca Yee, Peng Cui, Wanliang Shi, Jie Feng, Ying Zhang   +4 more
doaj   +1 more source

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles

International Journal of Mycobacteriology, 2018
Background: Tuberculosis (TB) has been identified in skeletons over 6000 years old and still remains as the most prevalent infectious disease in the world; thus, there is a need for development of new drugs or tuning of old drugs.
Kalaiselvi Kumarasingam, Mangayarkarasi Vincent, Shivshankar R Mane, Raja Shunmugam, S Sivakumar, K R Uma Devi   +5 more
doaj   +1 more source

Fabricating and Properties of Rifampicin-loaded Ethyl Cellulose Composites Via Electrospray

Studia Universitatis Babes-Bolyai Chemia
Rifampin (Rif) is usually applied as first-line anti-tubercular drugs but has limited bioavailability. Herein, Rif-loaded ethyl cellulose (EC) composites was designed and fabricated by electrospray to improve therapy effectiveness and duration.
Xi LI, Yanwen CHEN, Hong LI, Jiahao DING, Ya WANG, Jin MO, Mi ZHOU, Yaning LI, Qiuhan LIN, Boliang WANG   +9 more
doaj   +1 more source

Antileprotic medication induced psychosis in a patient of tuberous sclerosis: A case report

Indian Journal of Community and Family Medicine, 2017
Tuberous sclerosis is a rare multisystem neurocutaneous genetic disorder primarily presented with seizures, mental retardation and hamartomas involving multiple systems.
Udit Kumar Panda, Manas Ranjan Sahoo, Subhankar Swain   +2 more
doaj   +1 more source

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin

Acta Medica Indonesiana, 2016
Aim:to determine the effect of a rifampicin-containing tuberculosis regimen on efavirenz plasma concentrations and viral load in HIV/AIDS-Tuberculosis infection patients who received efavirenz-based antiretroviral therapy.
Nina Mariana, Purwantyastuti Purwantyastuti, Instiaty Instiaty, Adria Rusli   +3 more
doaj  

A novel approach for lung delivery of rifampicin-loaded liposomes in dry powder form for the treatment of tuberculosis

Lung India, 2015
Background: Lung administration of antibiotics by nebulization is promising for improved treatment efficiency for pulmonary infections, as it increases drug concentration at sites of infection while minimizing systemic side effects.
Jagadevappa S Patil, V Kusum Devi, Kshama Devi, S Sarasija   +3 more
doaj   +1 more source

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients

Brazilian Journal of Infectious Diseases
A prospective study was conducted on 79 advanced immunosuppressed AIDS patients from 1997 to 1999, during which nine cases of tuberculosis (TB) were diagnosed.
M.M. O'Donnel, S. Souza Carvalho, A.J. Gadelha, M.G. Morgado, M.C.G. Galhardo, M.C. Lourenço, V.C. Rolla   +6 more
doaj   +1 more source